Genetic Covariance Between γ-Glutamyl Transpeptidase and Fatty Liver Risk Factors: Role of β2-Adrenergic Receptor Genetic Variation in Twins

作者: Rohit Loomba , Fangwen Rao , Lian Zhang , Srikrishna Khandrika , Michael G. Ziegler

DOI: 10.1053/J.GASTRO.2010.06.009

关键词:

摘要: Background & Aims Plasma levels of γ-glutamyl transpeptidase (GGT) are associated with risk factors for nonalcoholic fatty liver disease (NAFLD), such as dyslipidemia, insulin resistance (IR), and hypertension. Limited data exist on whether there is genetic covariance between plasma GGT NAFLD factors. Variants β2-adrenergic receptor gene ( ADRB2 ) have been IR, hypertension, but its effect secretion not known. We estimated the heritability using a twin-study design examined levels, low-density lipoproteins triglycerides, variants. Methods studied phenotypes 362 twins; heritabilities increased activity were by variance-component methodology. genotype associations generalized estimating equations to account intra-twinship correlations. Results was heritable at 49% ± 8% twin cohort had significant IR; insulin, triglyceride, uric acid levels; diastolic blood pressure. In equation models, most common haplotype significantly activity. Five single nucleotide polymorphisms in GGT; haplotypes displayed pleiotropic effects triglyceride levels. Conclusions study, shared codetermination traits metabolic syndrome. The indicating linked pathways (eg, adrenergic) susceptibility

参考文章(60)
Carlos A. Isaza, Julieta Henao, Julio C. Sánchez, Gloria L. Porras, J. Cardona, G. Bedoya, Beta-2-Adrenergic Receptor Polymorphisms and Changes in Lipids Induced by Metoprolol Pharmacology. ,vol. 80, pp. 279- 285 ,(2007) , 10.1159/000106554
M. G. O'Riordain, J. A. Ross, K. C. Fearon, J. Maingay, M. Farouk, O. J. Garden, D. C. Carter, Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. American Journal of Physiology-endocrinology and Metabolism. ,vol. 269, ,(1995) , 10.1152/AJPENDO.1995.269.2.E323
Laura P. Svetkey, Phillip Z. Timmons, Osemwegie Emovon, Norman B. Anderson, Lisa Preis, Yuan-Tsong Chen, Association of Hypertension with β2- and α2c10-Adrenergic Receptor Genotype Hypertension. ,vol. 27, pp. 1210- 1215 ,(1996) , 10.1161/01.HYP.27.6.1210
C. M. Drysdale, D. W. McGraw, C. B. Stack, J. C. Stephens, R. S. Judson, K. Nandabalan, K. Arnold, G. Ruano, S. B. Liggett, Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 10483- 10488 ,(2000) , 10.1073/PNAS.97.19.10483
Eriko Ikai, Yuka Noborizaka, Ikiko Tsuritani, Ryumn Honda, Masao Ishizaki, Yuichi Yamada, Serum γ-Glutamyl Transpeptidase Levels and Hypertension in Non-drinkers: A Possible Role of Fatty Liver in the Pathogenesis of Obesity Related Hypertension Obesity Research. ,vol. 1, pp. 469- 474 ,(1993) , 10.1002/J.1550-8528.1993.TB00029.X
D W McGraw, S L Forbes, L A Kramer, S B Liggett, Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression. Journal of Clinical Investigation. ,vol. 102, pp. 1927- 1932 ,(1998) , 10.1172/JCI4862
Makoto Irie, Norihisa Suzuki, Tetsuro Sohda, Akira Anan, Kaoru Iwata, Yasuaki Takeyama, Hiroshi Watanabe, Peter Fischer, Jürgen E. Scherberich, Shotaro Sakisaka, Hepatic expression of gamma‐glutamyltranspeptidase in the human liver of patients with alcoholic liver disease Hepatology Research. ,vol. 37, pp. 966- 973 ,(2007) , 10.1111/J.1872-034X.2007.00151.X
Duk-Hee Lee, David R Jacobs, Myron Gross, Catarina I Kiefe, Jeffrey Roseman, Cora E Lewis, Michael Steffes, γ-Glutamyltransferase Is a Predictor of Incident Diabetes and Hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study Clinical Chemistry. ,vol. 49, pp. 1358- 1366 ,(2003) , 10.1373/49.8.1358
Sook-Kyoung Jo, Won-Young Lee, Eun-Jung Rhee, Jong-Chul Won, Chan-Hee Jung, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Sun-Woo Kim, Serum γ-glutamyl transferase activity predicts future development of metabolic syndrome defined by 2 different criteria Clinica Chimica Acta. ,vol. 403, pp. 234- 240 ,(2009) , 10.1016/J.CCA.2009.03.035